Literature DB >> 25518820

[Complex reconstruction with internal locking plate fixation for Charcot arthropathy].

F Ramadani1, H Härägus, P Radu, K Trieb, S Hofstaetter.   

Abstract

BACKGROUND: Osteosynthesis and reposition of the Charcot foot is challenging with respect to choice of a proper implant. There is currently no international consensus regarding the optimal implant.
OBJECTIVES: Locking plates seem to be an innovative and stable method for reconstruction. The aim of this work is to analyze bone fusion, complications, pseudoarthrosis, and patient satisfaction.
METHODS: This paper presents a retrospective analysis of 63 consecutive Charcot feet treated between 2004 and 2014. The mean follow-up time was 2.4 years.
RESULTS: All Charcot feet treated between 2004 and 2014 were Sanders type II or III. A bony fusion was achieved in 50 % of the cases, 26 % had a functional pseudoarthrosis with intact implants and pain-free mobility, and 22 % showed no healing with broken implants. Conclusion Internal fixation with locking plates is superior to screw fixation only with regard to biomechanics. We prefer internal fixation plates to external fixation because of stability even in the case of pseudoathrosis and because of the learning curve.

Entities:  

Mesh:

Year:  2015        PMID: 25518820     DOI: 10.1007/s00132-014-3061-0

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  13 in total

1.  [The Charcot joint].

Authors:  H Zwipp; S Rammelt; C Dahlen; H Reichmann
Journal:  Orthopade       Date:  1999-06       Impact factor: 1.087

Review 2.  Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review.

Authors:  Nicholas J Lowery; Jason B Woods; David G Armstrong; Dane K Wukich
Journal:  Foot Ankle Int       Date:  2012-02       Impact factor: 2.827

3.  Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy.

Authors:  Katherine M Raspovic; Dane K Wukich
Journal:  Foot Ankle Int       Date:  2013-12-18       Impact factor: 2.827

Review 4.  The costs of diabetic foot: the economic case for the limb salvage team.

Authors:  Vickie R Driver; Matteo Fabbi; Lawrence A Lavery; Gary Gibbons
Journal:  J Vasc Surg       Date:  2010-09       Impact factor: 4.268

Review 5.  Superconstructs in the treatment of charcot foot deformity: plantar plating, locked plating, and axial screw fixation.

Authors:  V James Sammarco
Journal:  Foot Ankle Clin       Date:  2009-09       Impact factor: 1.653

6.  [Reconstructive surgery for Charcot foot. Long-term 5-year outcome].

Authors:  U Illgner; M Podella; M Rümmler; J Wühr; H G Büsch; H H Wetz
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

7.  Long-term outcome and quality of life in patients with Charcot foot.

Authors:  Toni-Karri Pakarinen; Heikki-Jussi Laine; Heikki Mäenpää; Pentti Mattila; Jorma Lahtela
Journal:  Foot Ankle Surg       Date:  2009-04-05       Impact factor: 2.705

Review 8.  [Charcot foot. Current situation and outlook].

Authors:  T Mittlmeier; K Klaue; P Haar; M Beck
Journal:  Unfallchirurg       Date:  2008-04       Impact factor: 1.000

9.  German-Austrian consensus on operative treatment of Charcot neuroarthropathy: a Perspective by the Charcot task force of the German Association for Foot Surgery.

Authors:  Armin Koller; Ralph Springfeld; Gerald Engels; Raimund Fiedler; Ernst Orthner; Stefan Schrinner; Alexander Sikorski
Journal:  Diabet Foot Ankle       Date:  2011-11-09

10.  Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.

Authors:  Min-Woong Sohn; Rodney M Stuck; Michael Pinzur; Todd A Lee; Elly Budiman-Mak
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more
  1 in total

1.  Haematology panel biomarkers for humeral, femoral, and tibial diaphyseal fractures.

Authors:  Luchian Alexandru; Horia Haragus; Bogdan Deleanu; Bogdan Timar; Dan V Poenaru; Daliborca Cristina Vlad
Journal:  Int Orthop       Date:  2019-02-06       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.